Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation with Botulinum Toxin A for Myofascial Pain
NCT05605886Phase 1Unknown
- Sponsor
- Cairo University
- Start
- May 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of zinc in myofascial pain syndrome (MPS) (2 arms), sponsored by Cairo University. Primary endpoints: Muscular Activity at 4 months and Pressure Pain Threshold at 4 months. Status: unknown.
02
Drugs
zinc
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT05605886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05605886.